Wittkopp patent opposition analysis

The comprehensive analysis of Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
Stable Pharmaceutical Composition For Oral AdministrationASTELLAS PHARMA INC.Nov 12, 2026ALFRED E TIEFENBACHER
Ripretinib For Treating Gastrointestinal Stromal TumorsDECIPHERA PHARMACEUTICALS, LLCOct 22, 2026ALFRED E TIEFENBACHER
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZER INC.Sep 3, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Combination Comprising An Mek Inhibitor And A B-Raf InhibitorNOVARTIS AGAug 26, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Ribociclib TabletNOVARTIS AGAug 12, 2026STADA ARZNEIMITTEL
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)BenzamideACERTA PHARMA B.V.Aug 11, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICS, INC.Aug 3, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Methods Of Treating And/Or Preventing Actinic KeratosisATNX SPV, LLCJul 29, 2026MIBE
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 20, 2026SYNTHON
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMA, INCJun 17, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB